TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Avecho Biotechnology Limited ( (AU:AVE) ) just unveiled an update.
Avecho Biotechnology Limited has issued a correction to a previous announcement regarding the number of unquoted options issued on May 27, 2025. The corrected total number of unquoted options is 146,612,017, up from the initially reported 142,618,373, due to a typographical error. This update ensures accurate reporting of the company’s financial instruments, which is crucial for maintaining transparency with stakeholders and upholding regulatory compliance.
More about Avecho Biotechnology Limited
Avecho Biotechnology Limited operates in the biotechnology industry, focusing on the development and commercialization of innovative drug delivery systems. The company is known for its proprietary technology aimed at enhancing the bioavailability and efficacy of pharmaceutical and nutraceutical products.
Current Market Cap: A$19.04M
Learn more about AVE stock on TipRanks’ Stock Analysis page.